Lactoferrin for Prevention of COVID-19 in Health Care Workers
Status:
Terminated
Trial end date:
2021-02-10
Target enrollment:
Participant gender:
Summary
Clinical trial in health care personnel (physicians, nurses or nurse assistants) to determine
the effect of orally-administered bovine lactoferrin to prevent SARS-CoV-2 infection.
Participants will be randomized to receive daily bovine lactoferrin plus standard measures
during 12 weeks or placebo (maltodextrine) for the prevention of SARS-CoV-2. The target
enrollment is 336 participants. Each study participant will be monitored twice a week for
symptoms of COVID-19 and if symptoms occur, a RT-PCR will be performed. Additionally, we will
evaluate asymptomatic infections, by measuring SARS-CoV-2 serology every 4 weeks.